Economic evaluation of obinutuzumab in combination with chlorambucil in first-line treatment of patients with chronic lymphocytic leukemia in Spain

Overview of attention for article published in ClinicoEconomics and Outcomes Research: CEOR, September 2016

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

policy: 1 policy source

twitter: 2 X users

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 33 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,711 followers.

Economic evaluation of obinutuzumab in combination with chlorambucil i | CEOR https://t.co/04rdPw9itV

Reply Repost Favourite

Obinutuzumab in combination with chlorambucil in CLL https://t.co/Q3htlV38yv

Reply Repost Favourite